Recordati Rare Diseases Japan

Recordati Rare Diseases Japan Co., Ltd. is the Japanese arm of the Recordati Group's dedicated rare-disease business unit, Recordati Rare Diseases. According to its official website, the company began operations in Japan in October 2018 and was established in March 2018. It states that its mission is to contribute to the treatment of rare diseases by providing urgently needed medicines across key therapeutic areas, including metabolic diseases, endocrine diseases, and hematology/oncology. The company describes itself as a specialty company for rare diseases operating under the slogan 'Focused on the few', and notes the challenge of 'drug loss' in Japan, where new drugs approved in Europe and the United States may not be available on the Japanese market. Its registered office is in Akasaka, Minato-ku, Tokyo.

Recordati Rare Diseases Japan Co., Ltd. was established on March 5, 2018, and began operations in Japan in October 2018. It operates as the Japanese subsidiary of the Recordati Group, a pharmaceutical group that the company's website says began in the 1920s as a family-run pharmacy in Correggio, Italy, and has grown over about 100 years into a global pharmaceutical group listed on the Italian Stock Exchange with more than 4,450 employees. The Japanese entity is part of Recordati Rare Diseases, the group's dedicated business unit focused since 2007 on supporting the small number of patients suffering from lesser-known diseases. The company states that its mission is to contribute to the treatment of rare diseases by providing urgently needed medicines in key therapeutic areas, and that it works to address the 'drug loss' issue in Japan by introducing new drugs.

A specialty company focused on rare diseases, operating under the slogan 'Focused on the few'.

1. 1Recordati Rare Diseasesjp.recordatirarediseases.com
2. 2Recordati Rare Diseases Japan (Japan)wikidata.org